High circulating levels of adiponectin are associated with decreased risk of developing type 2 diabetes in middle aged individuals [14] and low adiponectin levels are reduced in states of insulin resistance (i.e., obesity and type 2 diabetes) [19, 20]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.